A total of 73 OCT Skin Imaging Publications in 2025
VivoSight OCT Publications surpass 800 With 73 new papers published in the past 12 months alone across Dermatology, Microneedle Array Patches, and Oral Medicine. This growing body of evidence highlights the expanding adoption of VivoSight as both a clinical tool and a research platform. In the development and validation of Microneedle Array Patches, VivoSight OCT ...
Michelson Diagnostics Achieves EU MDR Certification
Michelson Diagnostics, the leading provider of Optical Coherence Tomography (OCT) skin imaging systems, is proud to announce that it has been awarded CE Mark certification in Europe to MDR (Medical Device Regulation EU 2017/745) as a Class IIa medical device for its new VivoSight Dx Pro OCT system. MDR certification is recognised as one of ...
Societal benefits of faster skin cancer diagnosis highlighted
Optical Coherence Tomography, OCT, has the potential to speed and simplify diagnosis of Basal Cell Carcinoma Basal Cell Carcinoma, BCC, is the most common form of skin cancer and the most frequently occurring form of all cancers. Diagnosis of BCC usually involves the taking of a skin biopsy by a dermatologist, who will then send ...
Top-3 OCT Skin-Imaging publication topics in 2023
Optical Coherence Tomography, OCT, is being widely adopted for clinical, research and commercial skin-imaging applications As the leading dermatological OCT system VivoSight Dx has completed over 200,000 patient scans and has been used in over 500 peer-reviewed publications worldwide. During 2023 a total of 69 new peer-reviewed publications appeared featuring OCT imaging performed with VivoSight ...
